The BRIGHT Project

Following our information of April 2008 we are pleased to report that the project management headed by Prof. Dr. Sabina De Geest, University of Basel, Switzerland, succeeded in securing the funding of phase 1 of the project. in cooperation with the pharmaceutical company Astellas So the phase 1 of the project, a multi-centre observational study, including 1600 heart transplant patients from 40 transplant centres in 10 countries, which will investigate the factors affecting self management and patient compliance of immunosuppressive medication taking, can be initiated. We shall report separately on the further progress of this project.

Our friends

Our sponsors